Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
about
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemiaAPOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALLA Novel Cryptic Three-Way Translocation t(2;9;18)(p23.2;p21.3;q21.33) with Deletion of Tumor Suppressor Genes in 9p21.3 and 13q14 in a T-Cell Acute Lymphoblastic Leukemia.LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
P2860
Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bivalent promoter marks and a ...... xpression in T-cell leukaemia.
@en
type
label
Bivalent promoter marks and a ...... xpression in T-cell leukaemia.
@en
prefLabel
Bivalent promoter marks and a ...... xpression in T-cell leukaemia.
@en
P2093
P2860
P356
P1433
P1476
Bivalent promoter marks and a ...... xpression in T-cell leukaemia.
@en
P2093
B Göttgens
F J Calero-Nieto
J E Pimanda
K Knezevic
S J Kinston
P2860
P2888
P304
P356
10.1038/LEU.2013.2
P577
2013-01-10T00:00:00Z